Ken Kozuma

Proximal optimisation technique versus final kissing balloon inflation in coronary bifurcation lesions: the randomised, multicentre PROPOT trial

Watanabe Y, Murasato Y, Yamawaki M, Kinoshita Y, Okubo M, Yumoto K, Masuda N, Otake H, Aoki J, Nakazawa G, Numasawa Y, Ito T, Shite J, Okamura T, Takagi K, Kozuma K, Lefèvre T, Chevalier B, Louvard Y, Suzuki N, Kozuma K

October 20, 2021 | 10.4244/EIJ-D-20-01386

Reply: When is the optimal time point for detecting malapposition in coronary bifurcation trials?

Watanabe Y, Murasato Y, Suzuki N, Kozuma K

September 20, 2021 | 10.4244/EIJ-D-21-00445R

High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry

Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T, Murakami Y

February 19, 2021 | 10.4244/EIJ-D-20-00345

New three-dimensional rendering image of transoesophageal echocardiography for second transseptal puncture for transcatheter mitral valve repair

Nagura F, Kataoka A, Watanabe Y, Kozuma K

October 4, 2019 | 10.4244/EIJ-D-19-00049

Multislice computed tomography assessment of everolimus-eluting Absorb bioresorbable scaffolds in comparison with metallic drug-eluting stents from the ABSORB Japan randomised trial

Tanabe K, Popma J, Kozuma K, Saito S, Muramatsu T, Nakamura S, Namiki A, Morino Y, Hagiwara N, Uematsu M, Kawasaki T, Fujii K, Serruys P, Onuma Y, Ying S, Kusano H, Stone G, Kimura T

October 12, 2018 | 10.4244/EIJ-D-17-00716

Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT)

Natsuaki M, Kozuma K, Morimoto T, Kadota K, Muramatsu T, Nakagawa Y, Akasaka T, Hanaoka KI, Tanabe K, Morino Y, Nishikawa H, Kimura T

September 20, 2018 | 10.4244/EIJ-D-17-01050

Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?

Sotomi Y, Onuma Y, Miyazaki Y, Asano T, Katagiri Y, Tenekecioglu E, Jonker H, Dijkstra J, de Winter R, Wykrzykowska JJ, Stone G, Popma J, Kozuma K, Tanabe K, Serruys P, Kimura T

August 4, 2017 | 10.4244/EIJ-D-17-00070

Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve

Kawashima H, Watanabe Y, Kozuma K, Nara Y, Hioki H, Kataoka A, Yamamoto M, Takagi K, Araki M, Tada N, Shirai S, Yamanaka F, Hayashida K

March 20, 2017 | 10.4244/EIJ-D-16-00408

Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial

Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone G, Popma J, Onuma Y, Serruys P, Kimura T

February 20, 2017 | 10.4244/EIJ-D-16-00359

Comparative analysis method of permanent metallic stents (XIENCE) and bioresorbable poly-L-lactic (PLLA) scaffolds (Absorb) on optical coherence tomography at baseline and follow-up

Nakatani S, Sotomi Y, Ishibashi Y, Grundeken M.J, Tateishi H, Tenekecioglu E, Zeng Y, Suwannasom P, Regar E, Radu M, Räber L, Bezerra H, Costa M, Fitzgerald P, Prati F, Costa R, Dijkstra J, Kimura T, Kozuma K, Tanabe K, Akasaka T, Di Mario C, Serruys P, Onuma Y

December 20, 2016 | 10.4244/EIJY15M10_03

Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned

Morino Y, Tobaru T, Yasuda S, Kataoka K, Tanabe K, Hirohata A, Kozuma K, Kimura T

November 20, 2016 | 10.4244/EIJV12I10A208

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Igarashi K, Kozuma K, Tanabe K, Kusano H, Rapoza R, Popma J, Stone G, Simonton C, Serruys P, Kimura T

October 20, 2016 | 10.4244/EIJY16M09_01

Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?

Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon J, Collet C, de Winter R, Wykrzykowska JJ, Stone G, Popma J, Kozuma K, Tanabe K, Serruys P, Kimura T

October 10, 2016 | 10.4244/EIJV12I8A163

Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial)

Kubo T, Akasaka T, Kozuma K, Kimura K, Kawamura M, Sumiyoshi T, Ino Y, Morino Y, Tanabe K, Kadota K, Kimura T

September 22, 2015 | 10.4244/EIJV11I5A109

Peri-stent contrast staining and very late stent thrombosis after sirolimus-eluting stent implantation: an observation from the RESTART (REgistry of Stent Thrombosis for review And Re-evaluaTion) angiographic substudy

Kozuma K, Kimura T, Suzuki N, Miyazawa A, Waseda K, Honda Y, Morimoto T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Isshiki T

November 29, 2013 | 10.4244/EIJV9I7A137

Angiographic impact of the GuardWire system on inflated coronary segments after six months: does the distal protection balloon of the GuardWire Plus™ lead to restenosis?

Kyono H, Kozuma K, Muramatsu T, Suwa S, Fujita N, Koyama S, Saito M, Isshiki T

June 30, 2010

Ken Kozuma

Latest news